Skip to main content

Animations

MJFF Publications

5851 - 5875 of 9145 Results
Title
Year
  • Year
  • 2016
  • 2025
  • 2025
  • 2012
  • 2010
  • 2010
  • 2011
  • 2017
  • 2025
  • 2020
  • 2017
  • 2011
  • 2010
  • 2012
  • 2013
  • 2015
  • 2014
  • 2009
  • 2007
  • 2012
  • 2013
  • 2009
  • 2013
  • 2021
  • 2017
  • Summary Details
    OPEN
    Title: Self-Reported Symptoms of Parkinson’s Disease by Sex and Disease Duration
    Journal Name: Western Journal of Nursing Research
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0193945916670904
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligase
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2531025
    Citation Count: 4
  • Summary Details
    OPEN
    Title: External delay and dispersion correction of automatically sampled arterial blood with dual flow rates
    Journal Name: Biomedical Physics & Engineering Express
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/2057-1976/adae13
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.008
    Citation Count: 63
  • Summary Details
    OPEN
    Title: LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.04.002
    Citation Count: 150
  • Summary Details
    RESTRICTED
    Title: Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23221
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndrome
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.03.007
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.04.006
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson Disease: An Examination of Exercise Intensity
    Journal Name: Archives of Physical Medicine and Rehabilitation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.apmr.2025.12.008
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A New Approach to the Development of Disease‐Modifying Therapies for PD; Fighting Another Pandemic
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28310
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-017-07181-0
    Citation Count: 157
  • Summary Details
    OPEN
    Title: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032
    Citation Count: 72
  • Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    2010
    Summary Details
    OPEN
    Title: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008
    Citation Count: 187
  • Summary Details
    OPEN
    Title: Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders
    Journal Name: Occupational and Environmental Medicine
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/oemed-2011-100119
    Citation Count: 112
  • Summary Details
    OPEN
    Title: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038
    Citation Count: 43
  • Summary Details
    OPEN
    Title: M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.10.039
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020
    Citation Count: 45
  • Summary Details
    RESTRICTED
    Title: Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuint.2006.12.013
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2013.06.046
    Citation Count: 374
  • VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
    2009
    Summary Details
    OPEN
    Title: VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2009.10.011
    Citation Count: 77
  • Summary Details
    RESTRICTED
    Title: Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/nmt.12.75
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells10092286
    Citation Count: 22
  • Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
    2017
    Summary Details
    RESTRICTED
    Title: Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
    Journal Name: Clinical EEG and Neuroscience
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1550059417696179
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.